The K-ras mutation at codon 12 of exon 2 is implicated in the pathogenesis of pancreatic ductal adenocarcinoma (16) and has been identified in the spindle cell component of two examples of pancreatic sarcomatoid (spindle cell) carcinoma. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.